Clinical Charcteristics | All (n = 107) | eMVO + (n = 74) | eMVO - (n = 33) | p-value |
---|---|---|---|---|
Female, n(%) | 20 (18.5) | 13 (17.6) | 7 (21.2) | .421 |
Age, years | 56.8 ± 12.0 | 57.8 ± 12.2 | 54.6 ± 11.3 | .217 |
BMI, kg/m² | 25.5 ± 4.0 | 25.8 ± 2.7 | 24.9 ± 5.8 | .250 |
Hypertension, n (%) | 64 (59.8) | 48 (65.8) | 15 (45.5) | .040* |
Hypercholesterinemia, n(%) | 87 (81.3) | 61 (83.6) | 26 (78.8) | .367 |
Smoking, n(%) | 60 (56.1) | 37 (50.7) | 23 (69.7) | .052 |
Diabetes mellitus, n(%) | 9 (8.4) | 7 (9.6) | 2 (6.1) | .427 |
Family history for CVD, n(%) | 21 (19.6) | 14 (19.2) | 7 (21.2) | .500 |
Pain-to-balloon, min [median] | 210 (IQR: 120–330) | 210 (IQR: 150–338) | 180 (IQR: 60–270) | .553 |
Prehospital lysis, n (%) | 12 (11.1) | 7 (9.5) | 4 (12.1) | .456 |
TIMI pre PCI, n(%) | Â | Â | Â | .471 |
MEAN |  | 0.38 ± 0.8 | 0.58 ± 0.8 | .292 |
0 | 61 (72.6) | 46 (76.7) | 15 (62.5) | Â |
1 | 10 (11.9) | 6 (10.0) | 4 (16.7) | Â |
2 | 12 (14.3) | 7 (11.7) | 5 (20.8) | Â |
3 | 1(1.2) | 1 (1.7) | 0 (0) | Â |
TIMI post PCI, n(%) | Â | Â | Â | Â |
MEAN |  | 2.95 ± 0.4 | 2.84 ± 0.5 | .260 |
0 | 1 (1.2) | 1 (0) | 0 (0) | Â |
1 | 1 (1.2) | 0 (0) | 1 (4.0) | Â |
2 | 2 (2.3) | 0 (0) | 2 (8.0) | Â |
3 | 82 (95.3) | 60 (98.4) | 22 (88.0) | Â |
CKmax, U/l | 2460.3 ± 2026.7 | 2844.8 ± 1992.7 | 1492.4 ± 1802.5 | .002** |
cTnTmax, μg/ml | 6.96 ± 5.31 | 8.02 ± 5.19 | 4.30 ± 4.71 | .001** |
ST-Resolution, n(%) | 52 (80) | 33 (78.6) | 22 (81.8) | .517 |
Infarct size, g | 22.0 ± 16.0 | 24.9 ± 15.2 | 15.5 ± 16.1 | .006** |
Infarct transmurality, n(%) | Â | Â | Â | .002** |
MEAN |  | 98.2 ± 6.5 | 85 ± 25.1 | <.001** |
0-25 | 3 (3.0) | 0 | 3 (10.0) | Â |
25-50 | 2 (2.0) | 0 | 2 (6.7) | Â |
50-75 | 10 (10.0) | 5 (7.1) | 5 (16.7) | Â |
75-100 | 85 (85.0) | 65 (92.9) | 20 (66.7) | Â |
Ejection fraction, % | 41.1 ± 11.2 | 39.2 ± 11.4 | 46.1 ± 8.9 | .005** |
Early MVO, n(%) | 74 (69.2) | Â | Â | Â |
Late MVO, n(%) | 63 (58.9) | 59 (79.7) | 4 (12.1) | <.001** |
NYHA class at follow up, n(%) | Â | Â | Â | Â |
MEAN |  | 1.5 ± 0.8 | 1.2 ± 0.5 | .072 |
I | 73 (73.0) | 46 (67.6) | 26 (83.9) | Â |
II | 16 (16.0) | 12 (17.6) | 4 (12.9) | Â |
III | 9 (9.0) | 8 (11.7) | 1 (3.2) | Â |
IV | 2 (2.0) | 2 (2.9) | 0 (0) | Â |
CCS class at follow-up, n(%) | Â | Â | Â | Â |
MEAN |  | 0.43 ± 0.8 | 0.39 ± 0.7 | .808 |
0 | 71 (71.0) | 48 (70.6) | 22 (71.0) | Â |
I | 19 (19.0) | 13 (19.1) | 6 (19.4) | Â |
II | 9 (9.0) | 6 (8.8) | 3 (9.7) | Â |
III | 0 (0.0) | 0 (0) | 0 (0) | Â |
IV | 1 (1.0) | 1 (1.4) | 0 (0) | Â |